Accelovance,Inc.

Mishawaka, Indiana 46545

0 studies enrolling now · 2 studies all time

What they study most

Meningitis, Meningococcal, Meningococcal Vaccine

Studies at this site

• A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years — Completed
• A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years — Completed